Concentra Group Holdings Parent, Inc. (CON)
NYSEHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
$34.47-0.12%
Close 2026-09-04 · 1-day change
NYSEHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
QuarterlyIQ Insights · CON
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Entry into a Material Definitive Agreement. Stock Repurchase Agreement On August 21, 2026, Concentra Group Holdings Parent, Inc. (the “Company”) entered into a stock repurchase agreement (the “Stock Repurchase Agreement”) with Robert A. Ortenzio, chairman of the Company’s Board of Directors (the “Board”), and certain related entities listed on Schedule I thereto (the “Stockholders”) for the purchase by the Company of 1,000,000 shares of the Company’s common stock, $0.01 par value per share (t…
Other Events. Dividend Declaration On August 5, 2026, the Board of Directors declared a cash dividend of $0.0625 per share. The dividend will be payable on or about August 28, 2026, to stockholders of record as of the close of business on August 20, 2026.
Results of Operations and Financial Condition. On August 6, 2026, Concentra Group Holdings Parent, Inc. (the “Company”) issued a press release announcing its financial results for its second quarter ended June 30, 2026. A copy of the press release and financial schedules are attached as Exhibit 99.1 to this report and incorporated herein by reference. The information in this report (including Exhibit 99.1) is being furnished pursuant to
CEO — Keith Newton: Keith Newton is transitioning from CEO to Executive Chairman, with Matthew DiCanio succeeding him as President and CEO.
Executive Vice President and Chief Medical Officer — Dr. John R. Anderson: Dr. Anderson is retiring from his position and will continue as a consultant.
Other Events. Dividend Declaration On May 5, 2026, the Board of Directors declared a cash dividend of $0.0625 per share. The dividend will be payable on or about June 9, 2026, to stockholders of record as of the close of business on May 19, 2026.
Results of Operations and Financial Condition. On May 7, 2026, Concentra Group Holdings Parent, Inc. (the “Company”) issued a press release announcing its financial results for its first quarter ended March 31, 2026. A copy of the press release and financial schedules are attached as Exhibit 99.1 to this report and incorporated herein by reference. The information in this report (including Exhibit 99.1) is being furnished pursuant to
Executive Vice President and Chief Medical Officer — Dr. John Anderson: Dr. John Anderson is retiring from his position with a planned transition and consulting agreement.
Results of Operations and Financial Condition. On February 26, 2026, Concentra Group Holdings Parent, Inc. (the “Company”) issued a press release announcing its financial results for its fourth quarter and fiscal year ended December 31, 2025. A copy of the press release and financial schedules are attached as Exhibit 99.1 to this report and incorporated herein by reference. The information in this report (including Exhibit 99.1) is being furnished pursuant to
Other Events. Dividend Declaration On February 25, 2026, the Board of Directors declared a cash dividend of $0.0625 per share. The dividend will be payable on or about March 19, 2026, to stockholders of record as of the close of business on March 12, 2026.
Results of Operations and Financial Condition. On January 28, 2026 Concentra Group Holdings Parent, Inc. (“the Company”) issued a press release including preliminary, unaudited results of certain operational metrics for the fourth quarter and fiscal year ended December 31, 2025 (“the Press Release”). A copy of the Press Release and the attached financial schedules are attached as Exhibit 99.1 to this report and incorporated herein by reference. The information in this report (including Exhibi…
Forward-Looking Statements Any statements in this Current Report on Form 8-K or presentation about the Company’s future expectations, plans and prospects, including statements containing the words “believe,” “expect,” “intend,” “may,” “projects,” “will,” and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a resul…
Results of Operations and Financial Condition. On January 12, 2026, Concentra Group Holdings Parent, Inc. (the “Company”) published a presentation that includes preliminary, unaudited results of certain operational metrics for the quarter ended December 31, 2025, attached hereto as Exhibit 99.1. The Company will be presenting Exhibit 99.1 at the J.P. Morgan Healthcare Conference at 9:00 A.M. PT on Wednesday, January 14 th . A recording of the presentation will be published to the Company’s in…
The filing discloses routine annual equity grants to named executive officers, which is a compensatory arrangement rather than a change in management personnel.
Other Events. Dividend Declaration On November 5, 2025, the Company’s Board of Directors declared a cash dividend of $0.0625 per share. The dividend will be payable on or about December 9, 2025 to stockholders of record as of the close of business on December 2, 2025. Share Repurchase Program On November 5, 2025, the Board of Directors authorized a share repurchase program to repurchase up to $100 million of the Company's outstanding common stock. The share repurchase authorization will expir…
Results of Operations and Financial Condition. On November 6, 2025, Concentra Group Holdings Parent, Inc. (the “Company”) issued a press release announcing its financial results for its third quarter ended September 30, 2025. A copy of the press release and financial schedules are attached as Exhibit 99.1 to this report and incorporated herein by reference. The information in this report (including Exhibit 99.1) is being furnished pursuant to
Results of Operations and Financial Condition. On August 7, 2025, Concentra Group Holdings Parent, Inc. (the “Company”) issued a press release announcing its financial results for its second quarter ended June 30, 2025. A copy of the press release and financial schedules are attached as Exhibit 99.1 to this report and incorporated herein by reference. The information in this report (including Exhibit 99.1) is being furnished pursuant to
Other Events. Dividend Declaration On August 6, 2025, the Company’s Board of Directors declared a cash dividend of $0.0625 per share. The dividend will be payable on or about August 28, 2025 to stockholders of record as of the close of business on August 21, 2025.
Director — Brigid Bonner, Vipin Gopal: The filing discloses the appointment of two new directors to the board, which is a routine governance event and not a departure of a senior executive.
Regulation FD Disclosure. On June 2, 2025, the Company issued a press release announcing the consummation of the previously announced acquisition of all of the issued and outstanding equity interests of Onsite Innovations by CHS pursuant to the terms of the Purchase Agreement (the “Press Release”). A copy of the Press Release is attached as Exhibit 99.1 to this report and incorporated herein by reference. The information in this
Completion of Acquisition or Disposition of Assets Effective June 1, 2025, Concentra Health Services, Inc. (“CHS”), a wholly owned subsidiary of Concentra Group Holdings Parent, Inc. (the “Company”), consummated the previously announced acquisition of Onsite Innovations, LLC (“Onsite Innovations”), pursuant to the terms of an equity purchase agreement, dated April 18, 2025 (the “Purchase Agreement”), by and between CHS and Pivot Occupational Health, LLC (the “Seller”). Pursuant to the terms o…
Other Events. Dividend Declaration On May 6, 2025, the Company’s Board of Directors declared a cash dividend of $0.0625 per share. The dividend will be payable on or about May 29, 2025 to stockholders of record as of the close of business on May 20, 2025.
Results of Operations and Financial Condition. On May 7, 2025, Concentra Group Holdings Parent, Inc. (the “Company”) issued a press release announcing its financial results for its first quarter ended March 31, 2025. A copy of the press release and financial schedules are attached as Exhibit 99.1 to this report and incorporated herein by reference. The information in this report (including Exhibit 99.1) is being furnished pursuant to
Entry Into a Material Definitive Agreement. Equity Purchase Agreement On April 21, 2025, Concentra Group Holdings Parent, Inc. (the “Company”) announced that Concentra Health Services, Inc. (“CHS”), a wholly owned subsidiary of the Company, entered into an equity purchase agreement (the “Purchase Agreement”) with Pivot Occupational Health, LLC (the “Seller”) to acquire all of the outstanding equity interests of Onsite Innovations, LLC (“Onsite Innovations”) from the Seller (the “Transaction”)…
is being furnished solely to satisfy the requirements of Regulation FD and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act. Forward-Looking Statements Any statements in this Current Report on Form 8-K or the Press Release…
Importance-ranked changes since the prior daily snapshot.
Signal changed from 'favorable' to 'mild_favorable'.
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.